Advocates Must Press the CDC to Enforce its PrEP Patents in Order to End HIV as an Epidemic
TAG statement calling for advocates to stand with PrEP4All in demanding CDC enforce its PrEP patents.
Gene Editing in HIV Research
The purpose of this issue brief is to provide background information on gene editing in HIV research, and context for the news about researcher He Jiankui’s misuse of the technology to alter embryos (Chinese authorities have since declared He's experiments…
ANEA Statement on the President’s Fiscal Year 2020 Budget Proposal
The Act Now End AIDS coalition (Act Now End AIDS) expresses deep disappointment with the President’s Fiscal Year 2020 (FY 20) budget proposal for its failure to provide the fiscal resources, policy leadership, and political vision needed to end the HIV epidemic in the United States. TAG is a member of the coalition.
Treatment Action Group Statement on the President’s Fiscal Year 2020 Budget Proposal
Treatment Action Group (TAG) opposes the President's FY 2020 budget proposal, which makes a mockery of the administration's purported strategy to end AIDS in the United States over the next decade.
Pre-CROI Community HIV Cure Research Workshop 2019
On Sunday March 3, 2019 in Seattle, the AIDS Treatment Activists Coalition, AVAC, the DARE Community Advisory Board, the defeatHIV Community Advisory Board, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research. The…
EATAN HIV/AIDS & Hepatitis C Community Summit Report
In July, 2018, The European African Treatment Advocates Network (EATAN), in conjunction with TAG, held a Community Summit in Amsterdam, the Netherlands. EATAN focuses on supporting the medical and social needs of African migrant populations with HIV, HCV and other…
Statement on President Trump’s State of the Union Remarks on Ending the U.S. HIV Epidemic by 2030 from the Act Now: End AIDS Coalition
This statement was released last night by ANEA in response to the President’s SOTU announcement.
Public Comment on NIDA Strategic Plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse, and Addiction
TAG recently submitted a public comment to the National Institute on Drug Abuse (NIDA) at the National Institute of Health to inform a strategic plan it is developing to support research at the intersection of HIV and drug use.
Cutting Costs by Including Cheaper ARVs on the New York State Medicaid Preferred Drug List for treatment, PEP, and potentially PrEP
On January 17, 2019, Treatment Action Group and Housing Works presented this webinar discussing current advocacy to cut costs by scaling up the use of Mylan’s Cimduo (TDF/3TC) and Symfi (EFV/TDF/3TC) as part of New York State Medicaid. Tim Horn…
Public Comment on USPSTF Draft Recommendations for PrEP and HIV Screening
The US Preventive Services Task Force (USPSTF) recently released draft recommendations regarding HIV screening for all Americans ages 15-65, including pregnant women, and pre-exposure prophylaxis (PrEP) for individuals highly vulnerable to HIV infection.